Cowan Elvia

SVP, Finance & CAO

Cowan Elvia has filed 12 SEC Form 4 filings (31 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Nov 4, 2026.

On the most recent filing, Cowan Elvia is listed as SVP, Finance & CAO at Vaxcyte, Inc. Inside the rolling window, Cowan Elvia reported no open-market purchases and 6 open-market sales totaling $2.8M in PCVX. The largest disclosed transaction in the window is a sale of 19,000 PCVX shares on Oct 5, 2026, worth $1.6M.

Companies traded

Other insiders at PCVX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PCVXSale$183KNov 4SEC ↗
PCVXSale$1.6MOct 7SEC ↗
PCVXSale$180KApr 8SEC ↗
PCVXSale$105KMar 18SEC ↗
PCVXSale$146KMar 11SEC ↗
PCVXSale$557KDec 29SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Cowan Elvia made?

Cowan Elvia has filed 12 SEC Form 4 filings (31 transaction rows) across 1 company since 2025.

Which companies does Cowan Elvia trade?

Cowan Elvia has filed SEC Form 4 disclosures for 1 company, including PCVX.

When was Cowan Elvia's most recent SEC Form 4 filing?

Cowan Elvia's most recent SEC Form 4 filing on Tracefour is dated Nov 4, 2026.

What is Cowan Elvia's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Cowan Elvia is listed as SVP, Finance & CAO.

What is Cowan Elvia's total buy and sell value in the current window?

Inside the rolling retention window, Cowan Elvia bought $0 and sold $2.8M based on SEC Form 4 filings.

What was Cowan Elvia's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 19,000 PCVX shares on 2026-10-05, worth $1.6M, per SEC Form 4 filings.